Pliant Therapeutics Inc logo

Pliant Therapeutics Inc (PLRX) live share price

Pliant Therapeutics Inc share price in USD $13.8 & INR ₹1,166.64

$13.8

0.27

(2%)

View live Pliant Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Pliant Therapeutics Inc from India. Also see the sentimental analysis on Indian investors investing in Pliant Therapeutics Inc. Get details on the Indian mutual funds that are investing in Pliant Therapeutics Inc. Get Analyst recommendations and forecasts along with all the Pliant Therapeutics Inc's financials.

Pliant Therapeutics Inc share price movements

  • $13.40
    $13.85

    Day's Volatility :3.25%

  • $10.22
    $19.62

    52 Weeks Volatility :47.91%

Pliant Therapeutics Inc Returns

PeriodPliant Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
7.98%
-6.2%
0.0%
6 Months
14.52%
2.6%
0.0%
1 Year
-4.37%
11.8%
0.0%
3 Years
12.47%
13.8%
-17.6%

Pliant Therapeutics Inc Key Statistics

in dollars & INR

Market Capitalization
$823.3M
Revenue TTM
$0.0
EBITDA
$-220.0M
Earnings Per Share (EPS)
$-3.35
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-47.52%

How to invest in Pliant Therapeutics Inc from India?

It is very easy for Indian residents to invest directly in Pliant Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pliant Therapeutics Inc stock in both rupees (INR) and dollars (USD). Search for Pliant Therapeutics Inc or PLRX on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pliant Therapeutics Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pliant Therapeutics Inc shares which would translate to 0.061 fractional shares of Pliant Therapeutics Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Pliant Therapeutics Inc

67%

Period: Sep 2, 2024 to Dec 1, 2024. Change in 30 Days versus previous period

Search volume for Pliant Therapeutics Inc on INDmoney from India has grown in the last 30 days as on Dec 2, 2024. 67% more investors are searching Pliant Therapeutics Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Pliant Therapeutics Inc

  • Deep Track Capital, LP

    9.81%

  • BlackRock Inc

    8.17%

  • T. Rowe Price Associates, Inc.

    7.56%

  • FMR Inc

    6.41%

  • Vanguard Group Inc

    5.80%

  • Redmile Group, LLC

    5.25%

Analyst Recommendation on Pliant Therapeutics Inc

Buy

    95%Buy

    5%Hold

    0%Sell

Based on 20 Wall street analysts offering stock ratings for Pliant Therapeutics Inc(by analysts ranked 0 to 5 stars)

Based on 20 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
19
19
19
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Pliant Therapeutics Inc

What analysts predicted

Upside of 191.17%

Current:

$13.80

Target:

$40.18

Insights on Pliant Therapeutics Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 248.0K → 4.83M (in $), with an average increase of 94.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -41.10M → -57.76M (in $), with an average decrease of 12.2% per quarter
  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 47.6% return, outperforming this stock by 50.1%
  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 40.6% return, outperforming this stock by 36.8%

Pliant Therapeutics Inc Technicals Summary

Sell

Neutral

Buy

Pliant Therapeutics Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Pliant Therapeutics Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pliant Therapeutics Inc
-4.76%
14.52%
-4.37%
12.47%
-35.21%
Regeneron Pharmaceuticals, Inc.
-11.07%
-24.18%
-8.88%
18.12%
102.78%
Biontech Se
6.2%
15.09%
18.5%
-65.59%
454.0%
Alnylam Pharmaceuticals, Inc.
-7.61%
68.21%
46.39%
47.68%
107.47%
Vertex Pharmaceuticals Incorporated
-0.63%
-0.44%
33.51%
129.69%
109.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pliant Therapeutics Inc
NA
NA
NA
-3.63
-0.48
-0.28
NA
5.68
Regeneron Pharmaceuticals, Inc.
18.66
18.66
1.12
44.91
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.22
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pliant Therapeutics Inc
Buy
$823.3M
-35.21%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$83.0B
102.78%
18.66
33.61%
Biontech Se
Buy
$28.9B
454.0%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
107.47%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$119.6B
109.07%
32.84
-4.51%

About Pliant Therapeutics Inc

pliant therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. by harnessing the therapeutic potential of integrin biology and tgf-β modulation, pliant aims to prevent or even reverse fibrosis to address the needs of many patients. the company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. pliant’s co-founders include world-renowned researchers from university of california, san francisco (ucsf), who bring broad experience in fibrosis biology and small molecule chemistry. together, the pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.
Organization
Pliant Therapeutics Inc
Employees
166
CEO
Dr. Bernard Coulie M.B.A., M.D., Ph.D.
Industry
Health Technology

Important FAQs about investing in Pliant Therapeutics Inc from India :

What is Pliant Therapeutics Inc share price today?

Pliant Therapeutics Inc (PLRX) share price today is $13.80.

Can Indians buy Pliant Therapeutics Inc shares?

Yes, Indians can invest in the Pliant Therapeutics Inc (PLRX) from India.

With INDmoney, you can buy Pliant Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pliant Therapeutics Inc at zero transaction cost.

How can I buy Pliant Therapeutics Inc shares from India?

It is very easy to buy Pliant Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pliant Therapeutics Inc be purchased?

Yes, you can buy fractional shares of Pliant Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Pliant Therapeutics Inc stocks?

To start investing in Pliant Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pliant Therapeutics Inc

Today’s highest price of Pliant Therapeutics Inc (PLRX) is $13.85.

Today’s lowest price of Pliant Therapeutics Inc (PLRX) is $13.40.

What is today's market capitalisation of Pliant Therapeutics Inc

Today's market capitalisation of Pliant Therapeutics Inc PLRX is 823.3M

What is the 52 Week High and Low Range of Pliant Therapeutics Inc

  • 52 Week High

    $19.62

  • 52 Week Low

    $10.22

How much percentage Pliant Therapeutics Inc is down from its 52 Week High?

Pliant Therapeutics Inc (PLRX) share price is $13.80. It is down by 99% from its 52 Week High price of $19.62.

How much percentage Pliant Therapeutics Inc is up from its 52 Week low?

Pliant Therapeutics Inc (PLRX) share price is $13.80. It is up by 1% from its 52 Week Low price of $10.22.

What are the historical returns of Pliant Therapeutics Inc?

  • 1 Month Returns

    -4.76%

  • 3 Months Returns

    14.52%

  • 1 Year Returns

    -4.37%

  • 5 Years Returns

    -35.21%

Who is the Chief Executive Officer (CEO) of Pliant Therapeutics Inc

Dr. Bernard Coulie M.B.A., M.D., Ph.D. is the current Chief Executive Officer (CEO) of Pliant Therapeutics Inc.